Search Results - "de Albuquerque Rocha, Natalia"
-
1
Impact of empagliflozin in patients with diabetes and heart failure
Published in Trends in cardiovascular medicine (01-02-2017)“…Abstract Heart failure (HF) is a common disease with increased risk for mortality and morbidity among patients with type 2 diabetes mellitus (T2DM). Optimal…”
Get full text
Journal Article -
2
A randomized clinical trial evaluating the effect of empagliflozin on triglycerides in obese adults: Role of visceral fat
Published in Metabolism open (01-03-2022)“…Empagliflozin, a sodium glucose cotransporter 2 inhibitor, is a medication to treat type 2 diabetes. The effect of empagliflozin in persons without diabetes…”
Get full text
Journal Article -
3
Effects of Empagliflozin Treatment on Glycerol‐Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial
Published in Obesity (Silver Spring, Md.) (01-07-2020)“…Objective The aim of this study was to determine the effects of empagliflozin on glycerol‐derived hepatic gluconeogenesis in adults with obesity without type 2…”
Get full text
Journal Article -
4
Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach
Published in Current diabetes reports (01-09-2018)“…Purpose of Review With recent cardiovascular outcome trial (CVOT) results for antihyperglycemic medications, the treatment algorithm for patients with type 2…”
Get full text
Journal Article -
5
Effects of sodium glucose co-transporter 2 inhibitors on the kidney
Published in Diabetes & vascular disease research (01-09-2018)“…Sodium-glucose cotransporter 2 inhibitors are antihyperglycaemic medications with an emerging evidence base for cardiovascular and kidney disease risk…”
Get more information
Journal Article -
6
-
7
Diabetes medications and cardiovascular outcome trials: Lessons learned
Published in Cleveland Clinic journal of medicine (01-10-2017)“…The US Food and Drug Administration's current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New…”
Get full text
Journal Article -
8
Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen
Published in Reviews in cardiovascular medicine (30-03-2018)“…Diabetic dyslipidemia in type 2 diabetes (T2DM) is characterized by elevated levels of triglycerides (TG), decreased levels of high density…”
Get full text
Journal Article -
9
Effects of empagliflozin treatment on glycerol-derived hepatic gluconeogenesis in obese adults: a randomized clinical trial
Published in Obesity (Silver Spring, Md.) (01-07-2020)Get full text
Journal Article -
10
-
11
Lithium nephrotoxicity
Published in Revista da Associacao Medica Brasileira (1992) (01-09-2010)“…Lithium has been widely used in the treatment of bipolar disorder. Its renal toxicity includes impaired urinary concentrating ability and natriuresis, renal…”
Get more information
Magazine Article -
12
Nefrotoxicidade por lítio
Published in Revista da Associação Médica Brasileira (1992) (2010)Get full text
Magazine Article